1. Clinical significance of miRNAs in autoimmunity
   Lian Zhang et al, 2020, Journal of Autoimmunity CrossRef
2. The Genetics and Epigenetics of Primary Biliary Cholangitis
   Atsushi Tanaka et al, 2018, Clinics in Liver Disease CrossRef
3. Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis
   Aleksandar Arsenijevic et al, 2017, Analytical Cellular Pathology CrossRef
4. Huagan tongluo Fang improves liver fibrosis via down-regulating miR-184 and up-regulating FOXO1 to inhibit Th17 cell differentiation
   Ji Xuan et al, 2020, Experimental and Molecular Pathology CrossRef
5. The Role of Epigenetics in Primary Biliary Cholangitis
   Alessio Gerussi et al, 2022, International Journal of Molecular Sciences CrossRef
6. Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?
   Pedro M. Rodrigues et al, 2018, Journal of Hepatology CrossRef
7. Epigenetics of Primary Biliary Cholangitis
   Yikang Li et al, 2020, Epigenetics in Allergy and Autoimmunity CrossRef
8. HSCs-derived exosomes regulate the levels of inflammatory cytokines in HIBECs through miR-122-5p mediated p38 MAPK signaling pathway
   Yaqin Zhang et al, 2024, Genomics CrossRef
9. Immunological abnormalities in patients with primary biliary cholangitis
   Wen-Tao Ma et al, 2019, Clinical Science CrossRef
10. The Role of miRNA and Long Noncoding RNA in Cholestatic Liver Diseases
    Yudian Zhang et al, 2024, The American Journal of Pathology CrossRef
11. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
    Tomoko Tadokoro et al, 2021, International Journal of Molecular Sciences CrossRef
12. The role of miRNAs in the development of cholangiopathies. Part 1
    A.E. Abaturov et al, 2023, CHILD`S HEALTH CrossRef
13. Evolution of our understanding of PBC
    Atsushi Tanaka et al, 2018, Best Practice & Research Clinical Gastroenterology CrossRef
14. MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets
    Chen Huang et al, 2020, Biomedicine & Pharmacotherapy CrossRef
15. Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren’s Syndrome and Primary Biliary Cholangitis
    Pinelopi Arvaniti et al, 2019, Epigenomes CrossRef
16. Pathophysiology of primary biliary cholangitis
    Aliya F. Gulamhusein et al, 2018, Best Practice & Research Clinical Gastroenterology CrossRef
17. MicroRNAs in Liver Disease
    Ting Zhang et al, 2023, MicroRNA in Regenerative Medicine CrossRef
18. Erythrocyte miRNA-92a-3p interactions with PfEMP1 as determinants of clinical malaria
    Sowmya R. Prabhu et al, 2023, Functional & Integrative Genomics CrossRef
19. Epigenetics of autoimmune liver diseases: current progress and future directions
    Qiaoyan Liu et al, 2019, Journal of Bio-X Research CrossRef
20. Diagnostic and therapeutic potentials of microRNAs in cholangiopathies
    Lindsey Kennedy et al, 2017, Liver Research CrossRef
21. miR-181a regulates Th17 cells distribution via up-regulated BCL-2 in primary biliary cholangitis
    Yan Song et al, 2018, International Immunopharmacology CrossRef
22. The MicroRNA‐326: Autoimmune diseases, diagnostic biomarker, and therapeutic target
    Golamreza Jadideslam et al, 2018, Journal of Cellular Physiology CrossRef
23. Roles of Non-Coding RNAs in Primary Biliary Cholangitis
    Yaqin Zhang et al, 2022, Frontiers in Molecular Biosciences CrossRef